Company Overview of Viroblock SA
Viroblock SA engages in the development and marketing of antiviral products. It offers antiviral products with a mechanism of action against enveloped viruses, including human and avian influenzas, the hepatitis B and C viruses, and the AIDS virus. Its products and technologies are used in various prophylactic and therapeutic applications. Viroblock SA was founded in 2005 and is based in Geneva, Switzerland.
Chemin des Aulx 18
Founded in 2005
41 22 884 83 46
41 22 794 66 65
Key Executives for Viroblock SA
Similar Private Companies By Industry
|Acino International AG||Europe|
|AL-S Pharma AG||Europe|
|Albea Pharmaceuticals AG||Europe|
|Alpen Pharma AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Viroblock SA, please visit www.viroblock.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.